Federal award
SIEMENS HEALTHCARE DIAGNOSTICS INC.
N6809616F2017
Contract
Obligated and Ceiling
- Obligated (net)
- $170,682.03
- Ceiling (potential value, not spending)
- $170,682.03
- Current value
- $170,682.03
- Gross positive obligations
- $254,790.64
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- SIEMENS HEALTHCARE DIAGNOSTICS INC. · GC14SNHB3JN1
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- SIEMENS AKTIENGESELLSCHAFT · RDB2AM2GGHH8
- Awarding agency
- Department of Defense · sub-agency 1700 · office N68096
- Funding agency
- Department of Defense · sub-agency 1700
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
- PIID
- N6809616F2017
- Parent vehicle (IDV PIID)
- V797D30175
- Award type code
- C
- Actions
- 9 · Mar 2, 2016 to Apr 2, 2021
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Apr 2, 2021 | FY2021 | P00008 | D | −$24,488.40 | — |
| Jan 27, 2020 | FY2020 | P00007 | D | −$59,620.21 | — |
| Apr 18, 2018 | FY2018 | P00006 | M | $0.00 | — |
| Apr 3, 2018 | FY2018 | P00005 | M | $0.00 | — |
| Mar 16, 2018 | FY2018 | P00004 | G | $36,422.83 | — |
| Mar 8, 2017 | FY2017 | P00003 | G | $0.00 | — |
| Mar 3, 2017 | FY2017 | P00002 | M | $115,342.18 | — |
| Jul 8, 2016 | FY2016 | P00001 | M | $42,600.61 | — |
| Mar 2, 2016 | FY2016 | 0 | — | $60,425.02 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.
